journal
https://read.qxmd.com/read/38157654/remote-respiratory-resistance-exercise-training-improves-respiratory-function-in-individuals-with-vcp-multisystem-proteinopathy
#41
JOURNAL ARTICLE
Madeline Halseth, Ryan Mahoney, Joyce Hsiou, Harrison N Jones, Virginia Kimonis
Valosin-containing protein (VCP) disease is an autosomal dominant multisystem proteinopathy associated with hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Myopathy frequently results in respiratory muscle weakness, leading to early mortality due to respiratory failure. We investigated the effects of a remotely administered inspiratory muscle training program in individuals with VCP disease. Nine adults with VCP mutation-positive familial myopathy without evidence of dementia were recruited for a 40-week remotely administered study...
December 7, 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/38150892/raised-ck-and-acute-kidney-injury-following-intense-exercise-in-three-patients-with-a-history-of-exercise-intolerance-due-to-homozygous-mutations-in-slc2a9
#42
JOURNAL ARTICLE
Ros Quinlivan, Elaine Murphy, Shpresa Pula, Alexandra Pain, Henrietta Brain, Grace Scopes, Frenki Gjika, Naim Ahmadouk, Andreea Manole, Henry Houlden
Acute rhabdomyolysis (AR) leading to acute kidney injury has many underlying etiologies, however, when the primary trigger is exercise, the most usual underlying cause is either a genetic muscle disorder or unaccustomed intense exercise in a healthy individual. Three adult men presented with a history of exercise intolerance and episodes of acute renal impairment following intense exercise, thought to be due to AR in the case of two, and dehydration in one. The baseline serum CK was mildly raised between attacks in all three patients and acutely raised during attacks in two of the three patients...
December 6, 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/38157655/gain-and-loss-of-upper-limb-abilities-in-duchenne-muscular-dystrophy-patients-a-24-month-study
#43
JOURNAL ARTICLE
Giorgia Coratti, Marika Pane, Claudia Brogna, Adele D'Amico, Elena Pegoraro, Luca Bello, Valeria A Sansone, Emilio Albamonte, Elisabetta Ferraroli, Elena Stacy Mazzone, Lavinia Fanelli, Sonia Messina, Maria Sframeli, Michela Catteruccia, Gianpaolo Cicala, Anna Capasso, Martina Ricci, Silvia Frosini, Giacomo De Luca, Enrica Rolle, Roberto De Sanctis, Nicola Forcina, Giulia Norcia, Luigia Passamano, Marianna Scutifero, Alice Gardani, Antonella Pini, Giulia Monaco, Maria Grazia D'Angelo, Daniela Leone, Riccardo Zanin, Gian Luca Vita, Chiara Panicucci, Claudio Bruno, Tiziana Mongini, Federica Ricci, Angela Berardinelli, Roberta Battini, Riccardo Masson, Giovanni Baranello, Claudia Dosi, Enrico Bertini, Vincenzo Nigro, Luisa Politano, Eugenio Mercuri
Duchenne muscular dystrophy (DMD) is a neuromuscular condition characterized by muscle weakness. The Performance of upper limb (PUL) test is designed to evaluate upper limb function in DMD patients across three domains. The aim of this study is to identify frequently lost or gained PUL 2.0 abilities at distinct functional stages in DMD patients. This retrospective study analyzed prospectively collected data on 24-month PUL 2.0 changes related to ambulatory function. Ambulant patients were categorized based on initial 6MWT distance, non-ambulant patients by time since ambulation loss...
December 3, 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/38160563/bone-quality-in-lama2-related-muscular-dystrophy-and-selenon-related-congenital-myopathy-a-one-year-prospective-natural-history-study
#44
JOURNAL ARTICLE
Karlijn Bouman, Anne T M Dittrich, Jan T Groothuis, Baziel G M van Engelen, Heidi Zweers-van Essen, Anja de Baaij-Daalmeyer, Mirian C H Janssen, Corrie E Erasmus, Jos M T Draaisma, Nicol C Voermans
Fragility fractures are frequently reported in neuromuscular diseases and negatively influence functional prognosis, quality of life and survival. In LAMA2-related muscular dystrophy (LAMA2-MD) and SELENON(SEPN1)-related congenital myopathy (SELENON-RM) cross-sectional and prospective natural history studies on bone quality and fragility long bone fractures (LBFs) are lacking. We therefore aim to systematically assess bone quality and provide recommendations for clinical care. We performed a one-year prospective natural history study in 21 LAMA2-MD and 10 SELENON-RM patients including a standardized fracture history and bone quality assessment through dual energy Xray absorptiometry scan (DEXA-scan) and/or bone health index (BHI)...
December 2, 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/38150893/cost-effectiveness-of-spinal-muscular-atrophy-newborn-screening-based-on-real-world-data-in-belgium
#45
JOURNAL ARTICLE
Tamara Dangouloff, Praveen Thokala, Matthew D Stevenson, Nicolas Deconinck, Adèle D'Amico, Aurore Daron, Stephanie Delstanche, Laurent Servais, Mickael Hiligsmann
The objective of the study was to assess the cost-effectiveness of real-world spinal muscular atrophy newborn screening followed by treatment. We modeled the lifetime cost-effectiveness of the spinal muscular atrophy newborn screening followed by treatment (screening) compared to treatment without screening (no screening) from the Belgian healthcare perspective. Real-world data, including quality of life, costs, and motor development data, were collected on 12 patients identified by screening and 43 patients identified by their symptoms...
December 2, 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/38142474/continued-safety-and-long-term-effectiveness-of-onasemnogene-abeparvovec-in-ohio
#46
JOURNAL ARTICLE
Megan A Waldrop, Shannon Chagat, Michael Storey, Alayne Meyer, Megan Iammarino, Natalie Reash, Lindsay Alfano, Linda Lowes, Garey Noritz, Andre Prochoroff, Ian Rossman, Matthew Ginsberg, Kathryn Mosher, Eileen Broomall, Nancy Bass, Courtney Gushue, Kavitha Kotha, Grace Paul, Richard Shell, Chang-Yong Tsao, Jerry R Mendell, Anne M Connolly
5q spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disease caused by absence of the SMN1 gene with three FDA approved genetic therapies which significantly improve outcomes. The AAV9 mediated gene replacement therapy, onasemnogene abeparvovec, has the greatest potential for side effects. Here we report the safety and outcomes from 46 children treated with onasemnogene abeparvovec in the state of Ohio between December 2018 and January 2023. In our cohort, onasemnogene abeparvovec treatment remained safe and no child experienced any significant adverse events, including thrombotic microangiopathy, liver failure or death...
December 2, 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/38044217/corrigendum-to-nmnat1-and-hereditary-spastic-paraplegia-hsp-expanding-the-phenotypic-spectrum-of-nmnat1-variants-neuromuscular-disorders-33-2023-295-301
#47
Zahra Sadr, Aida Ghasemi, Mohammad Rohani, Afagh Alavi
No abstract text is available yet for this article.
December 2, 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/38030461/a-new-family-with-a-case-of-severe-early-onset-muscle-fatigue-and-a-peculiar-maternally-inherited-painful-swelling-in-chewing-muscles-associated-with-homoplasmic-m-15992a-t-mutation-in-mitochondrial-trna-pro
#48
JOURNAL ARTICLE
Elena Ghirigato, Francesca Terenzi, Mirko Baglivo, Nadia Zanetti, Francesco Baldo, Flora Maria Murru, Marco Bobbo, Egidio Barbi, Massimo Zeviani, Irene Bruno, Eleonora Lamantea
A 16-year-old boy was evaluated for a history of exercise-induced fatigability associated with nausea even after minimal effort, lower limbs muscle hypotrophy, and swelling of the masseter muscles after chewing. Laboratory tests were remarkable for hyperlactatemia and metabolic acidosis after short physical activity. The muscle biopsy showed non-specific mitochondrial alterations and an increase in intrafibral lipids. Biochemical analysis showed reduced activity of the respiratory chain complexes. Mitochondrial DNA sequencing revealed the presence of a homoplasmic variant m...
December 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/38016875/distal-myopathy-due-to-digenic-inheritance-of-tia1-and-sqstm1-variants-in-two-unrelated-spanish-patients
#49
JOURNAL ARTICLE
Laura Bermejo-Guerrero, Carlos Pablo de Fuenmayor Fernández-de la Hoz, Lidia González-Quereda, Alba Segarra-Casas, Velina Nedkova, Pia Gallano, Paloma Martín-Jiménez, Aurelio Hernández-Laín, Montse Olivé, Ana Arteche-López, Cristina Domínguez-González
Welander distal myopathy typically manifests in late adulthood and is caused by the founder TIA1 c.1150G>A (p.Glu384Lys) variant in families of Swedish and Finnish descent. Recently, a similar phenotype has been attributed to the digenic inheritance of TIA1 c.1070A>G (p.Asn357Ser) and SQSTM1 c.1175C>T (p.Pro392Leu) variants. We describe two unrelated Spanish patients presenting with slowly progressive gait disturbance, distal-predominant weakness, and mildly elevated creatine kinase (CK) levels since their 6th decade...
December 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/37989689/characterization-of-neuromuscular-performances-in-adults-with-late-onset-pompe-disease-a-control-case-cross-sectional-study
#50
JOURNAL ARTICLE
Théo Maulet, Céline Bonnyaud, Pascal Laforêt, Thomas Cattagni
Adults with late-onset Pompe disease (aLOPD) are characterized by muscular contractile tissue deterioration. However, their neuromuscular performances are poorly known. We aimed to compare maximal muscle strength, activation, explosive strength and neuromuscular fatigue between aLOPD and controls. We studied 20 aLOPD and 20 matched controls. Isometric maximum voluntary contraction (MVC) torque was obtained for the hip, knee and ankle muscles. The voluntary activation level (VAL) during knee extensor MVC was assessed using interpolated twitch technique...
December 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/37980206/a-brief-history-of-the-congenital-myopathies-the-myopathological-perspective
#51
JOURNAL ARTICLE
Hans H Goebel, Werner Stenzel
Congenital myopathies are defined by early clinical onset, slow progression, hereditary nature and disease-specific myopathological lesions - however, with exceptions - demanding special techniques in regard to morphological diagnostic and research work-up. To identify an index disease in a family requires a muscle biopsy - and no congenital myopathy has ever been first described at autopsy. The nosographic history commenced when - in addition to special histopathological techniques in the earliest classical triad of central core disease, 1956, nemaline myopathy, 1963, and centronuclear myopathy, 1966/67, within a decade - electron microscopy and enzyme histochemistry were applied to unfixed frozen muscle tissue and, thus, revolutionized diagnostic and research myopathology...
December 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/37945485/respiratory-function-in-a-large-cohort-of-treatment-na%C3%A3-ve-adult-spinal-muscular-atrophy-patients-a-cross-sectional-study
#52
JOURNAL ARTICLE
Alex Vicino, Luca Bello, Silvia Bonanno, Alessandra Govoni, Federica Cerri, Manfredi Ferraro, Giuliana Capece, Giulio Gadaleta, Megi Meneri, Veria Vacchiano, Giulia Ricci, Eustachio D'Errico, Irene Tramacere, Paolo Banfi, Sara Bortolani, Riccardo Zanin, Maria Antonietta Maioli, Mauro Silvestrini, Stefano Carlo Previtali, Angela Berardinelli, Mara Turri, Michela Coccia, Renato Mantegazza, Rocco Liguori, Massimiliano Filosto, Gabriele Siciliano, Isabella Laura Simone, Tiziana Mongini, Giacomo Comi, Elena Pegoraro, Lorenzo Maggi
Due to poor data in literature, we aimed to investigate the respiratory function in a large cohort of naïve Italian adult (≥18 years) SMA patients in a multi-centric cross-sectional study. The following respiratory parameters were considered: forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and need for non-invasive ventilation (NIV). We included 145 treatment-naïve adult patients (SMA2=18, SMA3=125; SMA4=2), 58 females (40 %), with median age at evaluation of 37 years (range 18-72)...
December 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/38142473/a-recurrent-acta1-amino-acid-change-in-mosaic-form-causes-milder-asymmetric-myopathy
#53
JOURNAL ARTICLE
Vilma-Lotta Lehtokari, Lydia Sagath, Mark Davis, Desiree Ho, Kirsi Kiiski, Kaisa Kettunen, Matthew Demczko, Riki Stein, Matteo Vatta, Thomas L Winder, Adi Shohet, Naama Orenstein, Peter Krcho, Peter Bohuš, Sanna Huovinen, Bjarne Udd, Katarina Pelin, Nigel G Laing, Carina Wallgren-Pettersson
We describe three patients with asymmetric congenital myopathy without definite nemaline bodies and one patient with severe nemaline myopathy. In all four patients, the phenotype had been caused by pathogenic missense variants in ACTA1 leading to the same amino acid change, p.(Gly247Arg). The three patients with milder myopathy were mosaic for their variants. In contrast, in the severely affected patient, the missense variant was present in a de novo, constitutional form. The grade of mosaicism in the three mosaic patients ranged between 20 % and 40 %...
November 30, 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/38052666/hnrnpa2b1-myopathy-presenting-in-a-family-with-an-early-onset-oculopharyngeal-muscular-dystrophy-like-phenotype
#54
Liam S Carroll, Sarah Ennis, Nicola Foulds, Simon R Hammans
Genetic variation at HNRNPA2B1 is associated with inclusion body myopathy, Paget's disease and paediatric onset oculopharyngeal muscular dystrophy. We present a pedigree where a mother and two daughters presented with adolescent to early-adulthood onset of symptoms reminiscent of oculopharyngeal muscular dystrophy or chronic progressive external ophthalmoplegia, with a later limb-girdle pattern of weakness. Creatine Kinase was ∼1000 U/L. Myoimaging identified fatty replacement of sartorius, adductors longus and magnus, biceps femoris, semitendinosus and gastrocnemii...
November 17, 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/38052667/acetaminophen-treatment-in-children-and-adults-with-spinal-muscular-atrophy-a-lower-tolerance-and-higher-risk-of-hepatotoxicity
#55
JOURNAL ARTICLE
Marie Mostue Naume, Qiaolin Zhao, Sissel Sundell Haslund-Krog, Thomas Krag, Brenda C M de Winter, Karoline Lolk Revsbech, John Vissing, Helle Holst, Morten Hylander Møller, Tessa Munkeboe Hornsyld, Morten Dunø, Christina Engel Hoei-Hansen, Alfred Peter Born, Per Bo Jensen, Mette Cathrine Ørngreen
Acute liver failure has been reported sporadically in patients with spinal muscular atrophy (SMA) and other neuromuscular disorders with low skeletal muscle mass receiving recommended dosages of acetaminophen. It is suggested that low skeletal muscle mass may add to the risk of toxicity. We aimed to describe the pharmacokinetics and safety of acetaminophen in patients with SMA. We analyzed acetaminophen metabolites and liver biomarkers in plasma from SMA patients and healthy controls (HC) every hour for six or eight hours on day 1 and day 3 of treatment with therapeutic doses of acetaminophen...
November 15, 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/37968166/in-memoriam-dr-martin-s-schwartz-md-baltimore-frcp-london-1941-2023
#56
JOURNAL ARTICLE
Michael Swash
No abstract text is available yet for this article.
November 13, 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/38042739/fatigue-and-associated-factors-in-172-patients-with-mcardle-disease-an-international-web-based-survey
#57
JOURNAL ARTICLE
Anna Slipsager, Linda Kahr Andersen, Nicol Cornelia Voermans, Alejandro Lucia, Walaa Karazi, Alfredo Santalla, John Vissing, Nicoline Løkken
McArdle disease is an autosomal recessive inherited disease caused by pathogenic variants in the PYGM gene, resulting in virtual absence of the myophosphorylase enzyme in skeletal muscle. Patients experience physical activity intolerance, muscle pain, and muscle fatigue. This study aimed to investigate other fatigue domains with the Multidimensional Fatigue Inventory (MFI-20) along with an investigation of potential contributing factors, including relevant disease and lifestyle-related factors. We conducted a survey in an international cohort of patients with McArdle disease...
November 11, 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/38016874/the-personal-financial-burden-associated-with-idiopathic-inflammatory-myopathies
#58
JOURNAL ARTICLE
Catherine Hua, Abhiram R Bhashyam, Manuel Lubinus, Lynn Wilson, Salman Bhai
The economic burden of idiopathic inflammatory myopathies (IIMs) within the US is underexplored. We hypothesized that IIMs patients experience considerable personal financial burden due to risks of multi-specialist visits, chronic long-term care, costs associated with disability, medical treatment, and overall high spending costs within the US healthcare system. We surveyed members of Myositis Support and Understanding (MSU) (response rate 4.7 %), and of the 470 survey participants that self-reported with diagnoses of IIMs, we assessed financial burden using two validated measures: (1) Financial Worry Score, and (2) Financial Burden Composite Score (FBCS)...
November 4, 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/38016873/the-dutch-registry-for-facioscapulohumeral-muscular-dystrophy-cohort-profile-and-longitudinal-patient-reported-outcomes
#59
JOURNAL ARTICLE
Joost Kools, Johanna Cw Deenen, Anna M Blokhuis, André Lm Verbeek, Nicol C Voermans, Baziel Gm van Engelen
Facioscapulohumeral dystrophy (FSHD) is the second most prevalent inherited muscular disorder and currently lacks a pharmaceutical treatment. The Dutch FSHD Registry was initiated in 2015 as a result of an international collaboration on trial readiness. This paper presents the cohort profile and six years of follow-up data of the registered FSHD patients. At the time of self-registration and every six months thereafter, participants were invited to complete a digital survey of patient and disease characteristics and the Dutch versions of the Checklist Individual Strength (CIS20R), the Individualised Neuromuscular Quality of Life Questionnaire (INQoL), the Beck Depression Index - Primary Care and the McGill Pain Questionnaire...
November 4, 2023: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/37996280/functional-characterization-of-ryr1-variants-identified-in-malignant-hyperthermia-susceptible-individuals
#60
JOURNAL ARTICLE
Yuko Noda, Hirotsugu Miyoshi, Sofia Benucci, Asensio Gonzalez, Oliver Bandschapp, Thierry Girard, Susan Treves, Francesco Zorzato
Malignant hyperthermia is a pharmacogenetic disorder triggered by halogenated anesthetic agents in genetically predisposed individuals. Approximately 70 % of these individuals carry mutations in RYR1, the gene encoding the ryanodine receptor calcium channel of skeletal muscle. In this study, we performed functional analysis of 5 RYR1 variants identified in members from 8 families who had been diagnosed by the IVCT. Of the 68 individuals enrolled in the study, 43 were diagnosed as MHS, 23 as MHN, and 2 individuals were not tested...
November 3, 2023: Neuromuscular Disorders: NMD
journal
journal
30818
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.